<DOC>
	<DOCNO>NCT01850459</DOCNO>
	<brief_summary>The purpose research study establish way help development target treatment autism spectrum disorder . This may also help early diagnosis autism may possibly predict severity . The study compare subject 's ERK ( extracellular signal-related kinase ) signal age- gender-matched neurotypical control Intelligence quotient ( IQ ) -matched developmental disability .</brief_summary>
	<brief_title>Extracellular Signal-Related Kinase Biomarker Development Autism</brief_title>
	<detailed_description>Autism Spectrum Disorder Subject Criteria : Inclusion Criteria : - Diagnosis autism spectrum disorder , base upon clinical interview utilize Diagnostic Statistical Manual-V ( DSM-V ) - Age 3-25 year - Stable dose psychotropic drug great equal 5 half-lives Exclusion Criteria : - Diagnosis schizophrenia , another psychotic disorder , bipolar disorder , alcohol substance abuse base Diagnostic Statistical Manual-V criterion - Use lithium , riluzole know modulators ERK activation Age-Matched Neurotypical Control Subjects : - Age match age Autistic Disorder Subject - History normal development IQ-Matched Control Subjects : - Those subject include study base IQ age match IQ age Autistic Disorder Subject IQ le 70 - All IQ-Matched Control Subjects also IQ less 70</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Autism Spectrum Disorder</mesh_term>
	<criteria>Inclusion Criteria ( ASD subject ) : Diagnosis autistic disorder confirm clinical interview , utilize DSMV Age 325 year Stable dose psychotropic drug 5 halflives great Exclusion Criteria ( ASD subject ) : Diagnosis schizophrenia , another psychotic disorder , bipolar disorder , alcohol substance abuse base DSMV criterion Use lithium , riluzole know modulators ERK activation IQMatched Control Subjects : Those subject include study base IQ age match IQ age Autistic Disorder Subject IQ less 70 . All IQMatched Control Subjects also IQ le 70 . IQMatched Control Subjects participate Screen/Baseline visit . AgeMatched Neurotypical Control Subjects : Those subject include study base age match age Autistic Disorder Subject history normal development . AgeMatched Neurotypical Subjects participate Screen/Baseline visit . Shipped Biomarker Control Group Subjects : For ship control sample , blood sample also draw adult parent/guardians participate subject .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>